Her3/ErbB3, His & Avi, Human
Her3/ErbB3, His & Avi, Human

Her3/ErbB3, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

Her3/ErbB3, His & Avi, Human

The purity of Her3/ErbB3, His & Avi, Human is greater than 95% as determined by SEC-HPLC.

Her3/ErbB3, His & Avi, Human

Immobilized Her3/ErbB3, His & Avi, Human at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Human NRG1 Beta 1, hFc Tag with the EC50 of 14.2 ng/ml determined by ELISA.

Her3/ErbB3, His & Avi, Human

Immobilized Her3/ErbB3, His & Avi, Human, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-HER3 Antibody, hFc Tag with the EC50 of 5.6 ng/ml determined by ELISA.

Her3/ErbB3, His & Avi, Human

Her3, also called ErbB3, is a type I membrane glycoprotein that is a member of the ErbB family of tyrosine kinase receptors. Her3 is expressed in keratinocytes, melanocytes, skeletal muscle cells, embryonic myoblasts and Schwann cells. Monomeric Her3 serves as a low affinity receptor for the heregulins (HRG).
Z03905
¥42,905.00

Ask us a question
Product Introduction
Species Human
Protein Construction
Her3/ErbB3 (Ser20-Thr643)
Accession # P21860-1		 His Avi
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Immobilized Her3/ErbB3, His & Avi, Human (Cat.No.: Z03905) 5 μg/ml (100μl/well) on the plate can bind Human NRG1 Beta 1, hFc Tag
Expression System HEK293
Theoretical Molecular Weight 71.6 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 90-110 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4.
Reconstitution It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O more than 100 μg/ml.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • Her3/ErbB3, His & Avi, Human
    • Her3/ErbB3, His & Avi, Human

    Her3/ErbB3, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

  • Her3/ErbB3, His & Avi, Human
    • Her3/ErbB3, His & Avi, Human

    The purity of Her3/ErbB3, His & Avi, Human is greater than 95% as determined by SEC-HPLC.

  • Her3/ErbB3, His & Avi, Human
    • Her3/ErbB3, His & Avi, Human

    Immobilized Her3/ErbB3, His & Avi, Human at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Human NRG1 Beta 1, hFc Tag with the EC50 of 14.2 ng/ml determined by ELISA.

  • Her3/ErbB3, His & Avi, Human
    • Her3/ErbB3, His & Avi, Human

    Immobilized Her3/ErbB3, His & Avi, Human, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-HER3 Antibody, hFc Tag with the EC50 of 5.6 ng/ml determined by ELISA.


Background
Target Background Her3, also called ErbB3, is a type I membrane glycoprotein that is a member of the ErbB family of tyrosine kinase receptors. Her3 is expressed in keratinocytes, melanocytes, skeletal muscle cells, embryonic myoblasts and Schwann cells. Monomeric Her3 serves as a low affinity receptor for the heregulins (HRG).
Synonyms ErbB3; ErbB-3; HER3; HER3c-erbB-3; LCCS2; MDA-BF-1; MGC88033; p180-ErbB3; p45-sErbB3; p85-sErbB3; ERBB3

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.